design
evalu
novel
decahydroisoquinolin
scaffold
inhibitor
sever
acut
respiratori
syndrom
sar
chymotrypsinlik
proteas
pro
describ
focus
hydrophob
interact
site
decahydroisoquinolin
scaffold
design
connect
p
site
cyclohexyl
group
substratebas
inhibitor
mainchain
anitrogen
atom
p
posit
via
methylen
linker
start
cyclohexen
enantiom
obtain
salt
resolut
transdecahydroisoquinolin
deriv
synthes
decahydroisoquinolin
inhibitor
synthes
show
moder
clear
inhibitori
activ
sar
pro
confirm
fuse
ring
structur
decahydroisoquinolin
function
novel
scaffold
sar
pro
inhibitor
xray
crystallograph
analys
sar
pro
complex
decahydroisoquinolin
inhibitor
reveal
expect
interact
site
well
addit
interact
nsubstitu
inhibitor
although
primari
epidem
sar
sever
acut
respiratori
syndrom
affect
patient
dead
eventu
brought
control
recent
identif
sar
cov
coronaviru
like
viru
chines
bat
novel
coronaviru
merscov
middl
east
respiratori
syndrom
corona
viru
previous
known
human
covemc
rais
possibl
reemerg
sar
relat
diseas
sinc
effect
therapi
exist
viral
infect
develop
antisar
agent
futur
outbreak
remain
formid
challeng
sar
positivesens
singlestrand
rna
viru
featur
largest
known
viral
rna
produc
two
larg
protein
overlap
sequenc
polyprotein
kda
kda
sar
chymotrypsin
like
proteas
pro
key
enzym
cleav
polyprotein
yield
function
polypeptid
pro
cystein
proteas
contain
cyshi
catalyt
dyad
exist
homodim
monom
contain
catalyt
dyad
activ
site
due
function
import
viral
life
cycl
pro
consid
attract
target
structurebas
design
drug
sar
thu
numer
inhibitor
pro
report
includ
peptidemim
small
molecul
deriv
natur
product
antivir
agent
antimalaria
agent
high
throughput
screen
cours
studi
sar
pro
inhibitor
found
addit
extra
sequenc
cterminu
matur
sar
pro
lower
catalyt
activ
matur
sar
pro
sensit
degrad
site
caus
loss
catalyt
activ
stabil
pro
dramat
increas
mutat
arg
posit
ile
enzymat
effici
mutant
increas
factor
potenc
mutant
proteas
make
possibl
quantit
evalu
substratebas
peptidemimet
inhibitor
easili
convent
hplc
use
substrat
peptid
contain
fluoresc
deriv
evalu
reveal
peptid
aldehyd
cover
psite
sequenc
substrat
acseralavalleunhch
ch
ch
con
ch
cho
inhibit
sar
pro
ic
valu
lm
systemat
modif
guid
xray
crystal
structur
seri
peptidemim
complex
sar
pro
result
ic
valu
nm
fig
sidechain
structur
differ
substrat
sequenc
except
p
site
sidechain
direct
outward
kinet
inhibit
data
obtain
lineweaverburk
plot
suggest
inhibitor
contain
aldehyd
cterminu
expect
function
competit
inhibitor
present
studi
design
novel
nonpeptid
inhibitor
focus
interact
site
pro
confirm
critic
make
potent
competit
inhibitor
among
key
interact
clarifi
xray
crystallograph
studi
focus
hydrophob
interact
cyclohexyl
sidechain
design
novel
inhibitor
scaffold
thu
cyclohexyl
ring
connect
mainchain
anitrogen
atom
p
posit
cha
cyclohexylalanin
via
methylen
linker
yield
compound
fig
result
decahydroisoquinolin
scaffold
expect
keep
hydrophob
interact
cyclohexyl
ring
substratebas
inhibitor
pocket
addit
result
decahydroisoquinolin
scaffold
arrang
p
site
imidazol
activ
site
function
aldehyd
requir
posit
give
fusedr
structur
decahydroisoquinolin
scaffold
novel
inhibitor
acyl
substitu
nitrogen
decahydroisoquinolin
scaffold
may
add
extra
posit
interact
pro
retro
synthet
rout
desir
decahydroisoquinolin
deriv
shown
scheme
p
site
deriv
could
introduc
reduct
amin
reaction
use
aldehyd
deriv
prepar
oxid
cleavag
olefin
bond
transdecahydroisoquinolin
scaffold
could
construct
via
pdmediat
stereoselect
intramolecular
cycliz
nucleophil
attack
nitrogen
atom
pdactiv
olefin
moieti
allyl
alcohol
olefin
structur
could
construct
horneremmon
reaction
util
aldehyd
precursor
amino
group
could
introduc
mitsunobu
reaction
alcohol
sixmemb
ring
structur
could
construct
dielsald
reaction
known
ester
butadien
thu
key
intermedi
precursor
pdmediat
cycliz
prepar
accord
rout
shown
scheme
known
ester
first
react
butadien
construct
sixmemb
ring
structur
yield
enantiom
mixtur
cyclohexen
product
reduc
lah
result
alcohol
protect
tertbutyldiphenylsilyl
ether
give
benzyl
group
remov
catalyt
hydrogen
reduc
cyclohexen
cyclohexan
time
result
hydroxyl
group
oxid
pcc
result
aldehyd
react
eto
p
ch
cooet
yield
ethyl
ester
reduc
dibalh
result
alcohol
protect
acetyl
ester
give
treatment
tbaf
result
alcohol
convert
azid
deriv
mitsunobu
reaction
sinc
product
rather
unstabl
immedi
reduc
correspond
amin
without
purif
amin
deriv
coupl
pphenylbenzo
acid
use
hbtu
yield
enantiom
mixtur
coupl
pbromobenzo
acid
similarli
conduct
yield
relat
deriv
construct
decahydroisoquinolin
scaffold
achiev
shown
scheme
ch
cn
pdcl
mediat
cycliz
gave
desir
transdecahydroisoquinolin
deriv
major
product
product
enantiom
mixtur
thought
rel
configur
due
cycliz
less
hinder
pdchelat
intermedi
thu
vinyl
substitu
product
thought
axial
clearli
confirm
xray
crystallograph
studi
inhibitor
complex
mutant
sar
pro
discuss
olefin
bond
oxid
cleav
treatment
k
oh
follow
naio
yield
aldehyd
reduct
amin
hhi
trt
n
och
ch
gave
coupl
product
diastereom
mixtur
separ
reversedphas
column
ymc
pack
od
analyt
hplc
fig
diastereom
could
also
separ
convent
silicagel
column
chromatographi
yield
diastereom
singl
peak
reversedphas
column
separ
diastereom
treat
tfa
cleav
trt
group
imidazol
ring
product
reduc
dibalh
yield
desir
aldehyd
although
absolut
configur
product
determin
stage
puriti
product
confirm
analyt
hplc
sinc
moder
clear
inhibitori
activ
observ
preliminari
evalu
inhibitori
potenc
identif
stereostructur
conduct
separ
prepar
diastereom
estim
absolut
configur
cyclohexen
carboxyl
acid
obtain
dielsald
reaction
convert
salt
r
amethylbenzylamin
resolv
accord
literatur
procedur
acid
scheme
resolut
carboxyl
acid
deriv
compound
compound
correspond
pbromobenzyl
group
gave
compound
show
polarimetr
charact
literatur
compound
carboxyl
acid
obtain
salt
format
r
amethylbenzylamin
follow
saltliber
hcl
wherea
salt
amethylbenzylamin
gave
carboxyl
acid
compar
literatur
valu
result
strongli
suggest
would
would
absolut
configur
optic
puriti
enantiom
confirm
use
chiral
column
ymc
chiral
amylosec
hplc
fig
sinc
chemic
yield
pbromobenzyl
deriv
superior
benzyl
deriv
enantiom
use
start
compound
separ
synthesi
decahydroisoquinolin
diastereom
separ
enantiom
use
synthes
correspond
decahydroisoquinolin
diastereom
use
basic
rout
scheme
enantiom
also
employ
synthes
diastereo
fig
comparison
also
conduct
pbromophenyl
nsubstitu
correspond
diastereom
result
obtain
fig
result
clearli
demonstr
two
diastereom
deriv
transdecahydroisoquinolin
structur
construct
enantiom
protect
diastereom
thu
synthes
convert
desir
deriv
without
difficulti
sever
analog
shown
tabl
contain
differ
nacyl
substitu
decahydroisoquinolin
scaffold
also
prepar
use
synthet
rout
fig
digest
substrat
peptid
sar
pro
presenc
decahydroisoquinolin
deriv
differ
concentr
conduct
accord
publish
procedur
inhibitori
activ
evalu
base
ic
valu
calcul
decreas
substrat
digest
sar
pro
typic
sigmoid
curv
use
estim
ic
valu
shown
figur
summar
tabl
synthes
decahydroisoquinolin
deriv
show
inhibitori
activ
mutant
pro
result
strongli
suggest
decahydroisoquinolin
fusedr
function
inhibitor
scaffold
comparison
ic
valu
transdecahydroisoquinolin
diastereom
deriv
vs
deriv
vs
clearli
show
isom
potent
isom
result
suggest
import
interact
pocket
mutant
pro
also
demonstr
seri
nbenzoyl
deriv
potent
deriv
substitut
benzoyl
substitu
halogen
show
signific
effect
inhibitori
activ
wherea
substitut
phenyl
group
nbiphenylacyl
deriv
gave
slightli
potent
inhibitor
biphenyl
deriv
result
suggest
substitu
nitrogen
atom
decahydroisoquinolin
scaffold
may
interact
sar
pro
clarifi
interact
newli
synthes
decahydroisoquinolin
inhibitor
sar
pro
structur
proteas
complex
inhibitor
reveal
xray
crystallographi
subsequ
cocryst
inhibitor
pro
prepar
analyz
structur
pro
complex
inhibitor
refin
resolut
respect
pdb
code
data
obtain
summar
tabl
overal
structur
pro
complex
inhibitor
ic
lm
first
compar
substratebas
inhibitor
pdb
code
fig
basic
decahydroisoquinolin
inhibitor
activ
site
cleft
pro
observ
highli
potent
inhibitor
aldehyd
group
imidazol
ring
hisal
well
decahydroisoquinolin
structur
almost
ident
conform
similarli
interact
pro
contrast
direct
pbromobenzoyl
group
outward
pro
opposit
p
p
site
npbromobenzoyl
group
howev
surfac
pro
addit
hydrophob
interact
met
pro
may
possibl
fig
carbonyl
carbon
aldehyd
group
detect
distanc
activ
center
thiol
electron
densiti
could
fit
sp
carbonyl
carbon
fig
result
suggest
decahydroisoquinolin
inhibitor
would
function
competit
inhibitor
peptidealdehyd
inhibitor
clearli
confirm
decahydroisoquinolin
scaffold
took
transfus
configur
expect
saltresolut
enantiomixtur
also
confirm
p
hisal
substitu
decahydroisoquinolin
scaffold
took
axialconfigur
expect
pd
ii
mediat
cycliz
decahydroisoquinolin
scaffold
insert
larg
pocket
creat
case
parent
peptid
aldehyd
inhibitor
pocket
occupi
fusedr
structur
decahydroisoquinolin
fig
nitrogen
atom
p
site
imidazol
form
hydrogen
bond
imidazol
nitrogen
result
close
fit
side
pocket
form
side
chain
proteas
fig
interact
especi
decahydroisoquinolin
scaffold
pocket
function
hold
p
site
imidazol
termin
aldehyd
tightli
insid
activ
site
cleft
result
compact
fit
novel
scaffold
pro
evalu
effect
absolut
configur
decahydroisoquinolin
scaffold
structur
pro
complex
decahydroisoquinolin
inhibitor
decahydroisoquinolin
inhibitor
compar
fig
inhibitor
p
site
imidazol
ring
termin
aldehyd
group
nearli
interact
nbromobenzoyl
decahydroisoquinolin
inhibitor
describ
due
configur
chang
decahydroisoquinolin
moieti
howev
decahydroisoquinolin
scaffold
clearli
twist
compar
decahydroisoquinolin
pocket
fig
conform
chang
decahydroisoquinolin
scaffold
transfer
direct
nsubstitu
thu
substitu
decahydroisoquinolin
took
nearli
conform
npbromobenzoyl
inhibitor
locat
surfac
pro
wherea
substitu
decahydroisoquinolin
direct
outsid
proteas
surfac
conform
differ
nsubstitu
well
interact
pocket
explain
discrep
inhibitori
activ
decahydroisoquinolin
inhibitor
vs
novel
nonpeptid
inhibitor
base
interact
site
sar
pro
design
synthes
focus
cleavag
site
interact
site
hydrophob
interact
site
decahydroisoquinolin
scaffold
design
use
cyclohexen
enantiom
obtain
salt
resolut
use
chiral
amin
transdecahydroisoquinolin
deriv
synthes
enantiom
sever
analog
contain
differ
nsubstitu
also
prepar
similarli
decahydroisoquinolin
inhibitor
show
moder
clear
inhibitori
activ
sar
pro
confirm
fuse
ring
structur
decahydroisoquinolin
scaffold
function
inhibitor
sar
pro
xray
crystallograph
studi
confirm
decahydroisoquinolin
inhibitor
activ
site
cleft
pro
observ
highli
potent
peptidealdehyd
inhibitor
decahydroisoquinolin
scaffold
insert
larg
pocket
occupi
pocket
p
site
imidazol
insert
pocket
expect
interact
effect
hold
termin
aldehyd
tightli
insid
activ
site
cleft
result
compact
fit
novel
scaffold
pro
acyl
substitu
nitrogen
decahydroisoquinolin
scaffold
surfac
pro
addit
interact
pro
may
possibl
evalu
analog
focus
interact
nsubstitu
underway
solvent
reagent
grade
thf
distil
sodium
benzophenon
ketyl
ch
cl
distil
cah
commerci
reagent
highest
puriti
avail
analyt
tlc
perform
silica
gel
mm
plate
column
chromatographi
carri
wakogel
particl
size
lm
wakogel
particl
size
lm
h
nmr
spectra
record
cdcl
unless
otherwis
state
agil
uniti
inova
nb
jeol
jnmec
bruker
jeol
jnmla
spectromet
chemic
shift
express
ppm
rel
tetramethylsilan
ppm
chcl
ppm
coupl
constant
given
hz
c
nmr
spectra
record
spectromet
mhz
use
central
reson
cdcl
c
ppm
intern
refer
unless
otherwis
state
highresolut
mass
spectra
hrm
obtain
fab
shimadzu
lcmsittof
esi
lowresolut
mass
spectra
lrm
obtain
shimadzu
esi
optic
rotat
determin
horiba
polarimet
prepar
hplc
perform
use
cosmosil
column
mm
linear
gradient
ch
cn
aqueou
tfa
flow
rate
mlmin
hitachi
lachrom
system
od
nm
analyt
hplc
unless
otherwis
note
cosmosil
column
mm
employ
linear
gradient
ch
cn
aqueou
tfa
flow
rate
mlmin
hitachi
lachrom
system
od
nm
puriti
test
compound
determin
analyt
hplc
test
compound
show
puriti
solut
wt
solut
hexan
ml
mmol
ad
ester
g
mmol
heat
h
reaction
mixtur
cool
room
temperatur
water
ad
whole
extract
acoet
organ
layer
wash
hcl
brine
dri
mgso
filter
concentr
residu
purifi
silica
gel
column
chromatographi
hexaneacoet
give
g
yellow
pale
oil
suspens
lialh
mg
mmol
ether
ml
ad
g
mmol
stir
min
reaction
quench
h
mixtur
warm
room
temperatur
filter
celit
silica
gel
layer
filtrat
concentr
residu
purifi
silica
gel
column
chromatographi
hexan
acoet
give
titl
alcohol
g
quant
colorless
oil
tbdpscl
ml
mmol
ad
solut
alcohol
g
mmol
imidazol
g
mmol
ch
cl
ml
mixtur
stir
h
reaction
quench
satur
aqueou
nh
cl
whole
extract
acoet
organ
layer
wash
brine
dri
na
filter
concentr
residu
purifi
silica
gel
column
chromatographi
hexaneacoet
give
g
quant
colorless
oil
solut
g
mmol
ch
ohacoetch
cl
ml
pd
oh
c
mg
ad
stir
hydrogen
ga
atmospher
room
temperatur
h
mixtur
filter
celit
silica
gel
layer
filtrat
dri
na
filter
concentr
residu
purifi
silica
gel
column
chromatographi
hexaneacoet
give
titl
alcohol
g
quant
colorless
oil
solut
pcc
g
mmol
celit
g
ch
cl
ml
alcohol
g
mmol
ad
temperatur
gradual
rais
room
temperatur
stir
h
reaction
mixtur
filter
silica
gel
layer
filtrat
concentr
compound
immedi
use
next
step
without
purif
triethylphosphonoacet
ml
mmol
ad
suspens
nah
miner
oil
mg
mmol
thf
ml
argon
ga
atmospher
mixtur
stir
h
oxid
product
ad
dropwis
reaction
mixtur
stir
h
reaction
quench
satur
aqueou
nh
cl
whole
extract
acoet
organ
layer
wash
brine
dri
na
filter
concentr
residu
purifi
silica
gel
column
chromatographi
hexan
acoet
give
g
step
colorless
oil
h
figur
xray
structur
inhibitor
complex
sar
pro
pdb
code
molecular
graphic
imag
around
p
p
site
ii
xray
structur
inhibitor
complex
sar
pro
ref
pdb
code
molecular
graphic
imag
around
p
p
site
solut
g
mmol
ch
cl
ml
dibalh
moll
solut
hexan
ml
mmol
ad
stir
min
temperatur
reaction
quench
ch
oh
ml
mixtur
warm
room
temperatur
filter
celit
silica
gel
layer
filtrat
dri
na
filter
concentr
residu
purifi
silica
gel
column
chromatographi
hexaneacoet
give
titl
alcohol
solut
alcohol
g
mmol
ch
cl
ml
pyridin
ml
mmol
acet
anhydrid
ml
mmol
dmap
mg
mmol
ad
mixtur
stir
room
temperatur
h
reaction
quench
satur
aqueou
nh
cl
mixtur
extract
acoet
organ
layer
wash
brine
dri
na
filter
concentr
residu
purifi
silica
gel
column
chromatographi
hexan
acoet
give
g
colorless
oil
solut
g
mmol
thf
ml
tbaf
solut
thf
ml
mmol
ad
room
temperatur
mixtur
stir
h
reaction
quench
satur
aqueou
nh
cl
whole
extract
acoet
organ
layer
wash
brine
dri
na
filter
concentr
residu
purifi
silica
gel
column
chromatographi
hexan
acoet
give
titl
alcohol
g
quant
colorless
oil
dppa
ml
mmol
ad
dropwis
solut
alcohol
g
mmol
triphenylphosphin
g
mmol
dead
solut
toluen
ml
mmol
thf
ml
mixtur
stir
h
temperatur
reaction
mixtur
concentr
residu
roughli
purifi
silica
gel
column
chromatographi
hexaneacoet
give
residu
use
next
step
without
purif
crude
product
ch
cl
ml
ad
solut
hbtu
g
mmol
dipea
ml
mmol
carboxyl
acid
mg
mmol
ch
cl
ml
mixtur
stir
h
room
temperatur
reaction
quench
satur
aqueou
nh
cl
extract
ch
cl
organ
layer
wash
brine
dri
na
filter
concentr
residu
purifi
silica
gel
column
chromatographi
hexaneacoet
afford
g
step
colorless
oil
titl
compound
similarli
prepar
colorless
oil
yield
step
solut
mg
mmol
dri
ch
cl
ml
ch
cn
pdcl
mg
mmol
ad
argon
ga
atmospher
mixtur
stir
temperatur
h
reaction
mixtur
filter
concentr
residu
purifi
silica
gel
column
chromatographi
hexaneacoet
give
mg
colorless
oil
product
use
without
purif
solut
hhi
trt
n
och
ch
mg
mmol
ch
cl
ml
acoh
ml
mmol
ad
mixtur
stir
room
temperatur
h
nabh
cn
mg
mmol
ad
result
mixtur
stir
min
reaction
quench
hcl
whole
extract
acoet
organ
layer
wash
satur
aqueou
nahco
brine
dri
na
filter
concentr
residu
purifi
flash
column
chromatographi
chcl
ch
oh
give
mmol
mixtur
stir
room
temperatur
h
mixtur
concentr
reduc
pressur
residu
dilut
acoet
basifi
satur
aqueou
nahco
whole
extract
acoet
organ
layer
wash
brine
dri
na
filter
concentr
residu
purifi
silica
gel
column
chromatographi
chcl
ch
oh
give
detrityl
product
solut
detrityl
product
mg
mmol
ch
cl
ml
dibalh
moll
solut
hexan
ml
mmol
ad
dropwis
reaction
mixtur
stir
min
reaction
quench
ch
oh
concentr
residu
dissolv
ch
filter
silica
gel
layer
filtrat
concentr
residu
purifi
hplc
give
solut
wt
solut
toluen
ml
mmol
ad
e
ethyl
oxi
g
mmol
mixtur
heat
h
reaction
mixtur
cool
room
temperatur
water
ad
whole
extract
acoet
organ
layer
wash
hcl
brine
dri
na
filter
concentr
residu
purifi
silica
gel
column
chromatographi
hexaneacoet
give
ethyl
ester
ethyl
oxi
ethyl
g
yellow
pale
oil
ml
stir
h
reflux
reaction
mixtur
cool
room
temperatur
mixtur
acidifi
hcl
whole
extract
acoet
organ
layer
wash
brine
dri
na
filter
concentr
residu
purifi
silica
gel
column
chromatographi
hexaneacoet
product
dissolv
acoet
ml
phenylethylamin
ml
mmol
ad
h
solid
collect
suction
filtrat
free
acid
liber
salt
treatment
hcl
extract
acoet
organ
layer
wash
brine
dri
na
filter
concentr
residu
purifi
silica
gel
column
chroma
solut
g
mmol
thf
ml
et
n
ml
mmol
ibcf
ml
mmol
ad
stir
min
temperatur
nabh
g
mmol
h
drop
pipett
ad
mixtur
warm
room
temperatur
reaction
quench
satur
aqueou
nh
whole
extract
acoet
organ
layer
wash
brine
dri
na
filter
concentr
residu
purifi
silica
gel
column
chromatographi
hexaneacoet
give
titl
alcohol
mmol
ch
cl
ml
mixtur
stir
h
room
temperatur
reaction
quench
satur
aqueou
nh
whole
extract
acoet
organ
layer
wash
brine
dri
na
filter
concentr
residu
purifi
silica
gel
column
chromatographi
hexaneacoet
give
diprotect
alcohol
compound
g
quant
colorless
oil
solut
diprotect
alcohol
g
mmol
ch
ohetoacsatur
aqueou
nahco
ml
pdc
g
ad
mixtur
stir
hydrogen
ga
atmospher
room
temperatur
h
mixtur
filter
celit
silica
gel
layer
filtrat
dri
na
filter
concentr
residu
purifi
silica
gel
column
chromatographi
hexaneacoet
give
trishcl
buffer
ph
contain
mm
dtt
incub
sar
nm
min
presenc
variou
inhibitor
concentr
min
cleavag
reaction
monitor
analyt
hplc
cosmosil
column
mm
linear
gradient
ch
cn
tfa
min
cleavag
rate
calcul
reduct
substrat
peak
area
ic
valu
obtain
sigmoid
doserespons
curv
see
fig
typic
sigmoid
curv
experi
repeat
time
result
averag
purifi
sar
pro
mm
bistri
ph
mm
nacl
mm
dtt
concentr
mgml
crystal
sar
pro
grown
use
sittingdrop
vapor
diffus
method
mix
equal
volum
reservoir
solut
contain
mm
me
ph
mm
dtt
cubicshap
crystal
dimens
mm
mm
mm
grew
within
day
crystal
soak
h
reservoirbas
solut
mm
me
ph
mm
dtt
contain
mm
crystal
transfer
cryobuff
mm
me
ph
mm
dtt
ethylen
glycol
contain
mm
flashfrozen
nitrogen
stream
k
xray
diffract
data
sar
pro
complex
inhibitor
collect
beamlin
rayonix
ccd
detector
wavelength
crystal
sar
pro
complex
obtain
cocrystal
use
sittingdrop
vapor
diffus
mix
equal
volum
proteininhibitor
complex
final
inhibitor
concentr
mm
reservoir
solut
contain
mm
me
ph
mm
dtt
cubicshap
crystal
dimens
mm
mm
mm
obtain
within
day
crystal
transfer
cryobuff
mm
me
ph
mm
dtt
ethylen
glycol
mm
flashfrozen
nitrogen
stream
k
xray
diffract
data
collect
rigaku
raxi
vii
imagingpl
detector
wavelength
equip
inhous
rotat
anod
fresup
bright
xray
gener
confoc
varimax
varimax
hf
optic
system
structur
sar
pro
complex
inhibitor
determin
molecular
replac
use
molrep
program
sar
pro
structur
pdb
code
search
model
rigid
bodi
refin
subsequ
restrain
refin
protocol
perform
program
refmac
ccp
packag
coot
program
use
manual
model
rebuild
water
molecul
ad
use
coot
refin
protein
structur
converg
ligand
gener
jligand
softwar
directli
built
correspond
differ
electron
densiti
model
subject
addit
round
refin
figur
structur
represent
gener
pymol
chimera
softwar
